MicroRNA-145 inhibits growth and migration of breast cancer cells through targeting oncoprotein ROCK1

M Zheng, X Sun, Y Li, W Zuo - Tumor Biology, 2016 - Springer
M Zheng, X Sun, Y Li, W Zuo
Tumor Biology, 2016Springer
MicroRNAs are small non-coding RNAs that may also function as oncogenes and tumor
suppressor genes, as the abnormal expression of microRNAs is associated with various
human tumors. MicroRNA-145 (miR-145) inhibits growth and increases chemo-or
radiosensitivity in various cancers. However, the role of miR-145 in breast cancer
progression remains unknown. In this study, miR-145 expression level was measured via
quantitative real-time PCR in 88 pairs of human breast cancer tissues and adjacent normal …
Abstract
MicroRNAs are small non-coding RNAs that may also function as oncogenes and tumor suppressor genes, as the abnormal expression of microRNAs is associated with various human tumors. MicroRNA-145 (miR-145) inhibits growth and increases chemo- or radiosensitivity in various cancers. However, the role of miR-145 in breast cancer progression remains unknown. In this study, miR-145 expression level was measured via quantitative real-time PCR in 88 pairs of human breast cancer tissues and adjacent normal tissues and in a panel of human breast cancer cell lines. Cell proliferation and cell migration were assessed by cell viability assay and transwell assay. Western blot was used to verify Rho-associated protein kinase 1 (ROCK1) as a novel target gene of miR-145. Our results showed that miR-145 was frequently downregulated in breast cancer tissues and cell lines. Overexpression of miR-145 in MCF-7 and BT-549 cell lines significantly inhibited cell proliferation, migration, and invasion in vitro. ROCK1 was identified as a target of miR-145, and ectopic expression of miR-145 downregulated ROCK1. Our findings indicate that miR-145 acts as a tumor suppressor and its downregulation in tumor tissues may contribute to the progression of breast cancer through a mechanism involving ROCK1, suggesting miR-145 as a potential new diagnostic and therapeutic target for the treatment of breast cancer.
Springer